维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

1篇 您的检索式：作者名="Shang‑Ying Hu"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Tackling barriers to scale up human papillomavirus vaccination in China:progress and the way forward显示文摘The human papillomavirus(HPV)vaccine is the first vaccine developed specifically targeting the prevention of cervical cancer.For more than 15 years,China has expedited a series of efforts on research and development of the domestically manufactured HPV vaccines,producing local population-based evidence,promoting free HPV vaccination from pilots,and launching action plans to tackle barriers in the scale-up of HPV vaccination.To further roll out the HPV vaccination program in China,several challenges should be addressed to support the steps forward.The availability of more locally manufactured HPV vaccines,pricing negotiation and local evidence supporting the efficacy of one-dose schedule would greatly alleviate the continued supply and financial constraints in China.Meanwhile,more attention should be paid to girls living in low-resource areas and males to ensure equal access to the HPV vaccination.Furthermore,linkage to secondary prevention and further real-world monitoring and evaluation are warranted to inform effective cervical cancer prevention strategies in the post-vaccine era.	Xue‑Lian Zhao Shang‑Ying Hu Jia‑Wei Hu Hong‑Hao Wang Tian‑Meng Wen Yu‑Shu Feng You‑Lin Qiao Fang‑Hui Zhao Yong Zhang	2023	Infectious Diseases of Poverty2023，12，5：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费